Come up with a name for your new list and we'll add to it:
nLife Therapeutics raised a round of funding on October 24, 2014. Investors include
The Michael J. Fox Foundation.
nLife Therapeutics develops treatments for CNS diseases and is working on next generation targeted nucleic acids products. The company's technology delivers conjugated nucleic acids with small chemica…